KDR and hepatocellular carcinoma: PIVKA-II not only promoted the secretion of other angiogenic factors in HCC cells but also induced KDR–PLC-γ–MAPK signaling pathway in vascular endothelial cells, leading to extracellular matrix degradation and cell migration (55, 56).